Lavipharm S.A. (0KDJ) Stock Statistics & Valuation Metrics

Lavipharm S.A. has a market cap or net worth of €259.58M. The enterprise value is €157.29M.

Lavipharm S.A. has 170,778,490 shares outstanding. The number of shares has decreased by -2.65% in one year.

Lavipharm S.A.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.11%.

The current PE Ratio of Lavipharm S.A. is 44.7. Lavipharm S.A.’s PEG ratio is ―.

In the last 12 months, Lavipharm S.A. had revenue of 62.58M and earned 5.99M in profits. Earnings per share was 0.04.

In the last 12 months, operating cash flow was 7.18M and capital expenditures -15.47M, giving a free cash flow of -8.29M billion.

Lavipharm S.A. pays an annual dividend of €0.019, resulting in a dividend yield of 1.41%

Lavipharm S.A. upcoming earnings date is Nov 17, 2025, TBA (Confirmed).

Lavipharm S.A. as a current ratio of 1.21, with Debt / Equity ratio of 67.97%

In the past 12 months, Lavipharm S.A. has paid 2.45M in taxes.

Lavipharm S.A. EV to EBITDA ratio is 15.06, with an EV/FCF ratio of 88.67.

Lavipharm S.A. has €3.62M in cash and marketable securities with €28.14M in debt, giving a net cash position of -€34.69M billion.

Gross margin is 44.96%, with operating margin of 11.44%, and net profit margin of 9.57%.

The average price target for Lavipharm S.A. is ―, which is 11.43% higher than the current price. The consensus rating is ―